SSC 2026 Guidelines now available — 129 adult & 61 pediatric recommendations View guidelines →

The Clinical Database
Vascular Access Emergency Medicine Critical Care Oncology Infection Prevention Blog About

Navigation

  • Home
  • Vascular Access
  • Emergency Medicine
  • Critical Care
  • Oncology
  • Infection Prevention
  • Blog
  • About
The Clinical Database
  • Home
Vascular Access
  • Overview
  • Guides
  • Policies
  • Guidelines
  • Patient Education
  • Resources
Emergency Medicine
  • Overview
  • Guidelines
Critical Care
  • Overview
  • Guidelines
Oncology
  • Overview
  • Guidelines
Infection Prevention
  • Overview
  • Guidelines
Blog
  • All Posts
  • Cortisol Levels in Hospital Staff and …
  • APIs Over Guidelines
  • IntracavOS: The Beautiful Paranoia of …
  • Healthcare is a Slow Moving Carcass
  • Introducing IntracavOS
Browse
  • For Clinicians
  • For Patients
  • Categories
  • About

Chemotherapy Extravasation Prevention and Management: A Comprehensive Clinical Guideline

Evidence-based guideline for prevention, recognition, and management of chemotherapy extravasation injuries, including agent classification, antidote protocols, and follow-up care.

3 articles • Updated Mar 2026

Chemotherapy Extravasation — Part 3: Follow-Up Care, Documentation, Legal Considerations, and Staff Education

Surgical consultation criteria, wound grading, patient follow-up protocols, peripheral vs. central line extravasation management, documentation requirements, incident reporting, legal considerations, staff competency assessment, and institutional protocol development.

guidelines•Mar 2026•guidelines

Chemotherapy Extravasation — Part 2: Recognition, Immediate Management, and Antidote Protocols

Signs and symptoms of extravasation (early and late), differential diagnosis, step-by-step immediate management algorithm, specific antidote protocols with complete dosing for dexrazoxane, hyaluronidase, sodium thiosulfate, and DMSO, and thermal management by agent class.

guidelines•Mar 2026•guidelines

Chemotherapy Extravasation — Part 1: Agent Classification, Risk Factors, and Prevention

Complete classification of antineoplastic agents by tissue damage potential (vesicants, irritants, non-vesicants), comprehensive risk factor analysis, and evidence-based prevention strategies including vein selection, device selection, and monitoring protocols.

guidelines•Mar 2026•guidelines

Clinical AI by Intracav

Need answers, not just guides?

The Clinical Database is the reference. Lumen is the clinical AI that answers questions from this content — sourced and at the point of care.

Try Lumen Free AI for Vascular Access →

© 2026 The Clinical Database

ESC
Type to search policies, guidelines, and blog posts
↑ ↓ Navigate ↵ Open ESC Close